PrECOG Protocol Number: PrE0405
Phase II Study of Bendamustine and Rituximab plus Venetoclax in Untreated Mantle Cell Lymphoma over 60 Years of Age

IRB/UVA Tracking #
21776
Contact
Erica Stallard
Contact Email
ELG9R@virginia.edu
Contact Phone
Phase
II
Primary purpose
Treatment
NCT
NCT03834688
Cancer PI
Craig Portell
Status
OPEN TO ACCRUAL
Ages
Adult